Neuroone Medical Technologies (NMTC) Total Current Liabilities (2010 - 2026)
Neuroone Medical Technologies' (NMTC) quarterly Total Current Liabilities came in at $1.7 million in Q1 2026, down 4.19% YoY from $1.8 million in Q1 2025, and up 34.25% on a QoQ basis from $1.3 million in Q4 2025.
Neuroone Medical Technologies (NMTC) Total Current Liabilities (2010 - 2026) Analysis & Trends
Neuroone Medical Technologies (NMTC) has 17 years of Total Current Liabilities data on file, last reported at $1.7 million in Q1 2026.
- Quarterly Total Current Liabilities fell 4.19% year-over-year to $1.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.7 million (down 4.19% YoY) and the FY2025 annual result came in at $2.3 million, up 4.06% from the prior year.
- Total Current Liabilities rose to $1.7 million in Q1 2026, from $1.3 million in the prior quarter.
- In the past five years, Total Current Liabilities ranged from a high of $3.1 million in Q3 2022 to a low of $810231.0 in Q1 2022.
- A 5-year average of $1.6 million and a median of $1.6 million in 2024 frame the typical range for Total Current Liabilities.
- Annual changes were most pronounced in 2022 — Total Current Liabilities jumped 162.22% — and 2023, when it sank 42.15%.
- Tracing NMTC's Total Current Liabilities over 5 years: stood at $1.3 million in 2022, then grew by 3.63% to $1.4 million in 2023, then climbed by 13.57% to $1.6 million in 2024, then fell by 19.89% to $1.3 million in 2025, then soared by 34.25% to $1.7 million in 2026.
- The last three Total Current Liabilities figures came in at $1.7 million (Q1 2026), $1.3 million (Q4 2025), and $2.3 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.51 Bn | 194.91 Bn | 7.27 Bn | 17.81 Bn |
| 2 | Stryker | 129.96 Bn | 126.48 Bn | 4.50 Bn | 6.68 Bn |
| 3 | Medtronic | 120.18 Bn | 110.96 Bn | 6.41 Bn | 11.66 Bn |
| 4 | Boston Scientific | 74.28 Bn | 73.74 Bn | 3.85 Bn | 6.43 Bn |
| 5 | Edwards Lifesciences | 52.75 Bn | 48.50 Bn | 1.35 Bn | 1.51 Bn |
| 6 | Dexcom | 34.67 Bn | 32.73 Bn | 830.00 Mn | 2.36 Bn |
| 7 | GE HealthCare Technologies | 34.23 Bn | 32.12 Bn | 2.18 Bn | 8.30 Bn |
| 8 | Koninklijke Philips | 26.46 Bn | 23.14 Bn | 4.55 Bn | 8.63 Bn |
| 9 | Steris | 23.30 Bn | 22.82 Bn | 684.20 Mn | 1.28 Bn |
| 10 | Neuroone Medical Technologies | 19.89 Mn | 17.84 Mn | 1.18 Mn | 2.04 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 2.04 Mn |
| Mar 31, 2026 | 1.69 Mn |
| Dec 31, 2025 | 1.26 Mn |
| Sep 30, 2025 | 2.30 Mn |
| Jun 30, 2025 | 1.43 Mn |
| Mar 31, 2025 | 1.76 Mn |
| Dec 31, 2024 | 1.57 Mn |
| Sep 30, 2024 | 2.21 Mn |
| Jun 30, 2024 | 1.69 Mn |
| Mar 31, 2024 | 1.54 Mn |
| Dec 31, 2023 | 1.38 Mn |
| Sep 30, 2023 | 1.79 Mn |
| Jun 30, 2023 | 1.75 Mn |
| Mar 31, 2023 | 1.55 Mn |
| Dec 31, 2022 | 1.33 Mn |
| Sep 30, 2022 | 3.10 Mn |
| Jun 30, 2022 | 814,519.00 |
| Mar 31, 2022 | 810,231.00 |
| Dec 31, 2021 | 1.06 Mn |
| Sep 30, 2021 | 1.18 Mn |